# Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia

> **NCT02151253** · PHASE2,PHASE3 · COMPLETED · sponsor: **Duke University** · enrollment: 81 (actual)

## Conditions studied

- Nocturia
- Daytime Sleepiness

## Interventions

- **DRUG:** Armodafinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02151253
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2017-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02151253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02151253, "Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02151253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*